1). Miyatake K, Omoto M, Kinoshita N, Izumi S, Owa M, Takao S, Sakakibara H, Nimura Y. Clinical application of a new type of real-time two-dimensional Doppler flow imaging system. Am J Cardiol. 54:857–868. 1984.
2). Jacobs LE, Kotler MN, Parry WR. Flow patterns in dilated cardiomyopathy: a pulsed-wave and color flow Doppler study. J Am Soc Echocardiogr. 3:294–302. 1990.
3). Garrahy PJ, Kwan OL, Booth DC, DeMaria AN. Assessment of abnormal systolic intraventricular flow patterns by Doppler imaging in patients with left ventricular dyssynergy. Circulation. 82:95–104. 1990.
Article
4). Beppu S, Izumi S, Miyatake K, Nagata S, Park YD, Sakakibara H, Nimura Y. Abnormal blood pathways in left ventricular cavity in acute myocardial infarction: experimental observations with special reference tio regional wall motion abnormality and hemostasis. Circulation. 78:157–164. 1988.
5). Feinstein SB, Ten Cate FJ, Zwehl W, Ong K, Maurer G, Tei C, Shah PM, Meerbaum S, Corday E. Two-dimensional contrast echocardiography: I in vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol. 3:14–20. 1984.
Article
6). Keller MW, Feinstein SB, Watson DD. Successful left ventricular opacification following a peripheral injection of a sonicated contrast agent: an experimental evaluation. Am Heart J. 114:570–575. 1987.
7). Keller MW, Glasheen WP, Teja K, Gear A, Kaul S. Myocardial contrast echocardiography without significant effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion. J Am Coll Cardiol. 12:1039–1047. 1988.
8). Feinstein SB, Cheirif J, Ten Cate FJ, Silverman PR, Heidenreich PA, Dick C, Desir RM, Armstrong WF, Quinones MA, Shah PM. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol. 16:316–324. 1990.
Article
9). Smith MD, Kwan OL, Reiser HJ, DeMaria AN, Evans J, Fritzsch TH. Superior intensity and reproducibility of SHU-454, a new right heart contrast agent. J Am Coll Cardiol. 3:992–998. 1984.
Article
10). Smith MD, Elion JL, McClure RR, Kwan OL, DeMaria AN, Evans J, Fritzsch TH. Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. J Am Coll Cardiol. 13:1622–1628. 1989.
Article
11). Shapiro JR, Reisner SA, Lichtenberg GS, Meltzer RS. Intravanous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol. 6:1607–1617. 1990.
12). Voci P, Bilotta F, Scibilia G, Mercanti C, Caretta Q, Marino B, Reale A. In vitro development and clinical applications of sonicated echo contrast agents. Am J Cardiac lmag. 5:192–199. 1991.
13). Gramiak R, Shah PM, Kramer DH. Ultrasound cardiography. Contrast studies in antomy and function. Radiology. 92:939. 1968.
14). Tei C, Shah PM, Ormiston JA. The assessment of tricuspid regurgitation by directional analysis of right atrial systolic linear reflux echoes with contrast M-mode echocardiograms. Am Heart J. 103:1025–1030. 1982.
15). Crouse LJ. Sonicated serum albumin in contrast echocardiography: improved segmental wall motion detection and implications for stress echocardiography. Am J Cardiol. 69:42H–45H. 1992.
16). Falcone RA, Marcovitz PA, Rasmussen C, Dittrich HC, Armstrong WF. Albunex increases identification of left ventricular endocardial borders during dobutamine stress echocardiography. J Am Soc Echocardiogr. 7:S29. 1994.
17). Tei C, Sakamaki T, Shah PM, Meerbaum S, Shimoura K, Kondo S, Corday E. Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficts. Circulation. 67:585–593. 1983.
18). Kabas JS, Kisslo J, Flick CL, Johnson SH, Craig DM, Stanley TE, Smith PK. Intraoperative perfusion contrast echocardiography. Initial experience during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 99:536–542. 1990.
19). Voci P, Bilotta F, Merialdo P, Eng C, Agati L. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a trasesophageal echocardiography dipyridamol study. J Am Soc Echocardiogr. 7:337–46. 1994.
20). Vandenberg BF. Myocardial perfusion and contrast echocardiography: review and new perspectives. Echocardiography. 8:65–75. 1991.
Article
21). Lim YJ, Nanto S, Masuyama T, Kodama K, Kohama A, Kitabatake A, Kamada T. Coronary collaterals assessed with myocardial contrast echocardiography in healed myocardial infarction. Am J Cardiol. 66:556–561. 1990.
Article
22). Heger JJ, Weyman AE, Qann LS, Togers EW, Dillon JC, Ferigenbaum H. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infaction. Circulation. 61:1113–1118. 1980.
23). Demaria AN, Bommer W, Kwan OL, Riggs K, Smith M, Waters J. In vivo correlation fo thermodilution cardiac output and videodensitometric indicator-dilution curves obtained from contrast two-dimensional echocardiograms. J Am Coll Cardiol. 3:999–1004. 1984.
24). Meerbaum S. Principles of echo contrast. Nanda N, Schlief R, editors. Advances in echo imaging using contrast enhancement. Kluwer Academic Publishers;The Nethelands: 1993. p. 9–42.
Article
25). Vuille C, Nidorf M, Morrissey RL, Newell JB, Weyman AE, Picard MH. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents. J Am Soc Echocardiogr. 7:347–354. 1994.
Article